INS and neoplasm: Recently, Sun et al. revealed that CD36 could negatively regulate insulin activation, indicating that CD36 interacted with IRS-1, thereby abrogating the binding between IRS-1 and CUL7, which would further increase IRS-1 stability and affect insulin signaling65 and might ultimately result in tumor suppression.